Literature DB >> 26139603

Rescue and Stabilization of Acetylcholinesterase in Skeletal Muscle by N-terminal Peptides Derived from the Noncatalytic Subunits.

Carlos A Ruiz1, Susana G Rossi1, Richard L Rotundo2.   

Abstract

The vast majority of newly synthesized acetylcholinesterase (AChE) molecules do not assemble into catalytically active oligomeric forms and are rapidly degraded intracellularly by the endoplasmic reticulum-associated protein degradation pathway. We have previously shown that AChE in skeletal muscle is regulated in part post-translationally by the availability of the noncatalytic subunit collagen Q, and others have shown that expression of a 17-amino acid N-terminal proline-rich attachment domain of collagen Q is sufficient to promote AChE tetramerization in cells producing AChE. In this study we show that muscle cells, or cell lines expressing AChE catalytic subunits, incubated with synthetic proline-rich attachment domain peptides containing the endoplasmic reticulum retrieval sequence KDEL take up and retrogradely transport them to the endoplasmic reticulum network where they induce assembly of AChE tetramers. The peptides act to enhance AChE folding thereby rescuing them from reticulum degradation. This enhanced folding efficiency occurs in the presence of inhibitors of protein synthesis and in turn increases total cell-associated AChE activity and active tetramer secretion. Pulse-chase studies of isotopically labeled AChE molecules show that the enzyme is rescued from intracellular degradation. These studies provide a mechanistic explanation for the large scale intracellular degradation of AChE previously observed and indicate that simple peptides alone can increase the production and secretion of this critical synaptic enzyme in muscle tissue.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ER quality control; enzyme processing; inactive precursors; membrane enzyme; protein folding; protein import; protein subunits

Mesh:

Substances:

Year:  2015        PMID: 26139603      PMCID: PMC4543640          DOI: 10.1074/jbc.M115.653741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  The mammalian gene of acetylcholinesterase-associated collagen.

Authors:  E Krejci; S Thomine; N Boschetti; C Legay; J Sketelj; J Massoulié
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

Review 2.  Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin.

Authors:  Kirsten Sandvig; Bo van Deurs
Journal:  FEBS Lett       Date:  2002-10-02       Impact factor: 4.124

3.  Acetylcholinesterase H and T dimers are associated through the same contact. Mutations at this interface interfere with the C-terminal T peptide, inducing degradation rather than secretion.

Authors:  N Morel; J Leroy; A Ayon; J Massoulié; S Bon
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

4.  Monitoring chaperone engagement of substrates in the endoplasmic reticulum of live cells.

Authors:  Erik L Snapp; Ajay Sharma; Jennifer Lippincott-Schwartz; Ramanujan S Hegde
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

5.  Biogenesis of acetylcholinesterase molecular forms in muscle. Evidence for a rapidly turning over, catalytically inactive precursor pool.

Authors:  R L Rotundo
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

6.  The assembly of proline-rich membrane anchor (PRiMA)-linked acetylcholinesterase enzyme: glycosylation is required for enzymatic activity but not for oligomerization.

Authors:  Vicky P Chen; Roy C Y Choi; Wallace K B Chan; K Wing Leung; Ava J Y Guo; Gallant K L Chan; Wilson K W Luk; Karl W K Tsim
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

7.  Intracellular transport, sorting, and turnover of acetylcholinesterase. Evidence for an endoglycosidase H-sensitive form in Golgi apparatus, sarcoplasmic reticulum, and clathrin-coated vesicles and its rapid degradation by a non-lysosomal mechanism.

Authors:  R L Rotundo; K Thomas; K Porter-Jordan; R J Benson; C Fernandez-Valle; R E Fine
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

8.  Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.

Authors:  C Kronman; T Chitlaru; E Elhanany; B Velan; A Shafferman
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

9.  Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.

Authors:  K Ohno; J Brengman; A Tsujino; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).

Authors:  C Donger; E Krejci; A P Serradell; B Eymard; S Bon; S Nicole; D Chateau; F Gary; M Fardeau; J Massoulié; P Guicheney
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

View more
  3 in total

Review 1.  Biogenesis, assembly and trafficking of acetylcholinesterase.

Authors:  Richard L Rotundo
Journal:  J Neurochem       Date:  2017-03-21       Impact factor: 5.372

2.  Polyproline-rich peptides associated with Torpedo californica acetylcholinesterase tetramers.

Authors:  Lilly Toker; Israel Silman; Tzviya Zeev-Ben-Mordehai; Joel L Sussman; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2020-02-20       Impact factor: 5.192

3.  The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.

Authors:  Lawrence M Schopfer; Hervé Delacour; Patrick Masson; Jacqueline Leroy; Eric Krejci; Oksana Lockridge
Journal:  Molecules       Date:  2017-06-29       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.